Cohort 1 Topline Data Expected in the Second Week of September 2026RESEARCH TRIANGLE PARK, N.C., July 09, 2026 (GLOBE ...
Opus Genetics, Inc. (Nasdaq: IRD) (the "Company", "Opus Genetics" or "Opus"), a clinical-stage biopharmaceutical company developing gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results